Myelitis, Transverse [clinicaltrials_resource:4d066456a090932b92ab1a559cd65478]
condition [clinicaltrials_vocabulary:condition]
Phase III Randomized, Double-Blind, Sham-Controlled Study of Plasma Exchange for Acute Severe Attacks of Inflammatory Demyelinating Disease Refractory to Intravenous Methylprednisolone [clinicaltrials:NCT00004645]clinicaltrials:NCT00179478A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic’s Disease) [clinicaltrials:NCT00304291]Biobank For MS And Other Demyelinating Diseases [clinicaltrials:NCT00445367]Safety and Tolerability of Rituximab in Neuromyelitis Optica [clinicaltrials:NCT00501748]Serum Auto-Antibodies [clinicaltrials:NCT00704626]clinicaltrials:NCT01446575Maintenance Plasma Exchange for Neuromyelitis Optica [clinicaltrials:NCT01500681]A Longitudinal Study of Neuromyelitis Optica and Transverse Myelitis [clinicaltrials:NCT01623076]PCORI Transverse Myelitis CAPTURE [clinicaltrials:NCT02144935]clinicaltrials:NCT02166346clinicaltrials:NCT02276963clinicaltrials:NCT02341950clinicaltrials:NCT02398994
condition browse [clinicaltrials_vocabulary:condition-browse]
Phase III Randomized, Double-Blind, Sham-Controlled Study of Plasma Exchange for Acute Severe Attacks of Inflammatory Demyelinating Disease Refractory to Intravenous Methylprednisolone [clinicaltrials:NCT00004645]clinicaltrials:NCT00179478A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic’s Disease) [clinicaltrials:NCT00304291]Biobank For MS And Other Demyelinating Diseases [clinicaltrials:NCT00445367]Safety and Tolerability of Rituximab in Neuromyelitis Optica [clinicaltrials:NCT00501748]Serum Auto-Antibodies [clinicaltrials:NCT00704626]clinicaltrials:NCT01446575Maintenance Plasma Exchange for Neuromyelitis Optica [clinicaltrials:NCT01500681]A Longitudinal Study of Neuromyelitis Optica and Transverse Myelitis [clinicaltrials:NCT01623076]PCORI Transverse Myelitis CAPTURE [clinicaltrials:NCT02144935]clinicaltrials:NCT02166346clinicaltrials:NCT02276963clinicaltrials:NCT02341950clinicaltrials:NCT02398994
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Myelitis, Transverse [clinicaltrials_resource:4d066456a090932b92ab1a559cd65478]
Bio2RDF identifier
4d066456a090932b92ab1a559cd65478
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:4d066456a090932b92ab1a559cd65478
identifier
clinicaltrials_resource:4d066456a090932b92ab1a559cd65478
title
Myelitis, Transverse
@en
type
label
Myelitis, Transverse [clinicaltrials_resource:4d066456a090932b92ab1a559cd65478]
@en
Myelitis, Transverse